CQS Cayman’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

CQS Cayman’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-153,291	Closed	-$26.5M	–	260
2015 Q1	$26.5M	Buy	153,291 +113,291	+283%	+$16.6M	1.25%	11
2014 Q4	$4.6M	Buy	+40,000	New	+$4.85M	0.31%	78

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

CQS Cayman's SLXP Position: Q2 2015 in Review

CQS Cayman sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 153,291 shares — an estimated $26.5M sold.

CQS Cayman first reported a position in SLXP in Q4 2014 and held it in 2 quarters. The position peaked at $26.5M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

CQS Cayman reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
CQS Cayman sold 153,291 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $26.5M.
CQS Cayman first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q4 2014 and held it in 2 quarters.
CQS Cayman's SALIX PHARMACEUTICALS LTD DEL position peaked at $26.5M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on CQS Cayman's 13F filing for Q2 2015, filed 12 Aug 2015.